All In MedTech

Device Trial Radar · NCT00996489

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

Post-approval of Coaptite® in the Treatment of Female Urinary Incontinence

Last checked: Nov 20, 2026Latest source record: Jul 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

459

Actual

Start

Jan 8, 2008

Primary completion

Oct 26, 2015

Study completion Nov 2, 2015

Sponsor

Lead sponsor
Merz North America, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 16, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a post approval study of Coaptite® in the treatment of female urinary incontinence.

Conditions

  • Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Interventions

  • Coaptite®Device

    Calcium hydroxylapatite particles suspended in an aqueous based gel carrier

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incontinence Status as Assessed by Stamey Grade ScoreTime frame: Baseline and Months 6, 12, 18, 24, 30, and 36
  2. Number of Participants With One Point Improvement in Stamey Grade Scores up to Month 12Time frame: Baseline up to Month 12
  3. Number of Participants Who Had at Least One Point Improvement in Stamey Grade Scores Compared to BaselineTime frame: Months 6, 12, 18, 24, 30, and 36

2 more outcomes with a free account

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Wetumpka, Alabama

  • Site not named

    Surprise, Arizona

  • Site not named

    Encinitas, California

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.